Peptide Variant Screening
Peptide Variant Screening - Related Videos
02:42
A Fluorogenic Peptide Cleavage Assay to Screen the Proteolytic Activity of Proteases
0 Views •
2025
This video demonstrates an assay to screen for the proteolytic activity of proteases using fluorogenic peptides. The protease recognizes its cleavage site on the peptide, cleaving it and separating the quencher from the fluorophore, enabling its fluorescence emission. The fluorescence signal is detected and analyzed to check for the cleavage efficiency of different peptide variants.
03:37
Assessing the Antimicrobial Activity of Nisin Variants Using an Agar Well Diffusion Assay
0 Views •
2025
Source: Nickling, J. H., et.al. Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids. J. Vis. Exp. (2018)This video demonstrates an agar well diffusion assay used to evaluate the antimicrobial activity of nisin variants. It shows how Lactococcus lactis expressing the membrane-bound peptidase NisP activates nisin precursors produced in E. coli, resulting in growth inhibition halos. The size of these halos reflects the bioactivity of each nisin variant.
12:38
Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells
0 Views •
Cited by 2 •
2021
Techniques for generating a library of short peptides that can activate mast cells via the MRGPRX2 receptor are described. Associated techniques are easy, inexpensive, and can be extended to other cell receptors.
09:10
A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes
0 Views •
Cited by 3 •
2018
Here we present the proteogenomic tool PoGo and protocols for fast, quantitative, post-translational modification and variant enabled mapping of peptides identified through mass spectrometry onto reference genomes. This tool is of use to integrate and visualize proteogenomic and personal proteomic studies interfacing with orthogonal genomics data.
02:30
Histone Variants at the Centromere
0 Views •
2020
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
FAQs
Amino acid changes can alter a peptide’s biological activity and its recognition by antibodies, T cells, or receptors. Comparing related sequences helps connect specific composition changes with differences in binding, immune activation, or inhibition. This sequence-to-response relationship can reveal which variant features are associated with stronger or weaker immune recognition.
Binding, activation, and inhibition measure different aspects of peptide behavior, so a variant may produce different results across assay types. Testing the response that matches the research question helps distinguish recognition from downstream immune activity. This comparison is useful when interpreting whether a sequence change affects interaction, cellular response, or functional interference.
Controlled conditions make responses from different peptide sequences more comparable. When variants are evaluated with the same relevant antibodies, T cells, receptors, or assay systems, observed differences are more directly associated with sequence changes rather than inconsistent testing conditions. This supports clearer conclusions about how composition relates to immune response.
A typical workflow begins by generating or selecting peptide variants, followed by exposure to a relevant immune component or assay system. Researchers then measure outcomes such as binding, activation, or inhibition under controlled conditions. Comparing these results across sequences identifies variants with altered activity and supports selection for later diagnostic, vaccine, therapeutic, or mechanistic work.
Researchers can compare peptide sequences that differ in ways associated with pathogen variation and examine how immune responses change. Reduced or altered recognition by antibodies, T cells, or receptors may indicate a shift in antigenicity, meaning the immune system responds differently to the variant. These comparisons help connect sequence change with potential immune consequences in infection research.
The method is useful for identifying immune-recognized epitopes, clarifying how sequence variation relates to response, and prioritizing peptide candidates. Its findings can inform diagnostic development, vaccine research, therapeutic investigation, and mechanistic studies. By ranking variants according to measured binding, activation, or inhibition, researchers can focus subsequent work on the most informative sequences.